Madhura Kelkar

2017-2021 National Institute of Immunohaematology (ICMR), Mumbai 
"Madhura Kelkar"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rathod M, Kelkar M, Valvi S, et al. (2020) FOXA1 Regulation Turns Benzamide HDACi Treatment Effect-Specific in BC, Promoting NIS Gene-Mediated Targeted Radioiodine Therapy. Molecular Therapy Oncolytics. 19: 93-104
Rathod M, Kelkar M, Salvi G, et al. (2018) PO-022 Benzamide class of HDACi differentially enhance sodium iodide symporter expression in breast cancer Esmo Open. 3: A236
Agrawal S, Kelkar M, De A, et al. (2018) Newly emerging mesoporous strontium hydroxyapatite nanorods: microwave synthesis and relevance as doxorubicin nanocarrier Journal of Nanoparticle Research. 20: 230
Kelkar MG, Thakur B, Derle A, et al. (2017) Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer. Breast Cancer Research and Treatment
Kelkar MG, Senthilkumar K, Jadhav S, et al. (2016) Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation. Scientific Reports. 6: 19341
Agrawal S, Kelkar M, De A, et al. (2016) Surfactant free novel one-minute microwave synthesis, characterization and cell toxicity study of mesoporous strontium hydroxyapatite nanorods Rsc Advances. 6: 94921-94926
Srivastava M, Nambiar M, Sharma S, et al. (2012) An inhibitor of nonhomologous end-joining abrogates double-strand break repair and impedes cancer progression. Cell. 151: 1474-87
Kelkar M, De A. (2012) Bioluminescence based in vivo screening technologies. Current Opinion in Pharmacology. 12: 592-600
See more...